Hydrogel Ionic Circuit Device for Wound Biofilm Debridement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for chronic wound biofilm infections, such as debridement and long-term antibiotic administration, are inefficient and can cause tissue damage, with biofilms exhibiting high tolerance to antibiotics due to protective extracellular polymeric substances and slow antibiotic diffusion, leading to prolonged healing times and increased healthcare burdens.
Innovation Solution
A hydrogel ionic circuit (HIC)-based device that applies high-intensity electrical current for biofilm debridement and iontophoretic antibiotic delivery, using a salt solution chamber and a therapeutic solution chamber separated by a hydrogel membrane to enhance antibiotic penetration and biofilm removal without causing significant pH or temperature changes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional debridement and long-term antibiotic administration are used to treat chronic wound biofilm infections, then bacterial burden is reduced, but treatment duration is prolonged and tissue damage occurs
Solution Approach 1:
The patent replaces conventional mechanical debridement and chemical antibiotic administration with electrical field-based treatment. Electrical fields directly disrupt biofilm structure and enhance antibiotic penetration through iontophoresis, achieving faster bacterial burden reduction without prolonged treatment duration. The electrical field acts as a physical force that penetrates the protective EPS matrix, eliminating the need for long-term topical antibiotic application.
Solution Approach 2:
The patent changes the treatment parameter from chemical concentration (antibiotic dosage) to electrical field intensity and duration. By applying controlled electrical fields, the system enhances the penetration and efficacy of antibiotics without increasing treatment time. The electrical parameter modification allows rapid disruption of biofilm and enhanced drug delivery, resolving the contradiction between efficacy and treatment duration.
2Reliability
If high concentrations of antibiotics are used to penetrate biofilm, then bacterial killing efficacy is improved, but antibiotic resistance and tissue toxicity increase
Solution Approach 1:
The patent introduces electrical fields as an intermediary mechanism to enhance antibiotic penetration. The electrical field acts as a mediator that facilitates the transport of antibiotics through the biofilm EPS matrix and into bacterial cells, achieving high concentrations at the infection site without requiring system-wide high-dose administration. This localized delivery reduces tissue toxicity while maintaining killing efficacy.
Solution Approach 2:
The patent segments the treatment approach into two complementary components: electrical field application for biofilm disruption and enhanced penetration, and targeted antibiotic delivery for bacterial killing. This segmentation allows each component to work at optimized levels, achieving high efficacy without the harmful effects of excessive antibiotic concentrations throughout the entire tissue.
3Reliability
If repeated debridement is performed to reduce biofilm, then bacterial burden is reduced, but pain and damage to healthy tissues occur
Solution Approach 1:
The patent substitutes mechanical debridement with electrical field-based biofilm disruption. Electrical fields penetrate the biofilm and disrupt bacterial cell membranes and EPS matrix without requiring physical contact or mechanical force. This non-contact approach eliminates the pain and tissue damage associated with repeated surgical debridement while achieving equivalent or superior biofilm reduction.
Solution Approach 2:
The patent employs periodic electrical field application rather than repeated mechanical debridement. The electrical fields can be applied in controlled cycles, disrupting biofilm structure and enhancing antibiotic penetration without the need for repeated invasive procedures. This periodic electrical action reduces tissue damage while maintaining effective biofilm reduction.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The HIC-based device effectively reduces biofilm bacterial counts to below the clinical threshold, promoting wound healing by combining rapid biofilm debridement and high-concentration antibiotic delivery, reducing treatment duration and minimizing tissue damage.
Implementation Method 1
the hydrogel membrane is ionically conductive and configured to transmit the ion current
Implementation Method 2
an electrode configured to apply an electrical current to the chamber to induce an ion current in the salt solution
Data Source
AI summary
Systems and methods for treating and inhibiting wound infections employ a hydrogel ionic circuit (HIC)-based device for therapeutic iontophoresis and/or biofilm debridement. The HIC-based device includes: a first chamber containing a salt solution; a second chamber containing a therapeutic or buffer solution, the second chamber being configured to interface with a surface overlaying a target region; a hydrogel membrane separating the first chamber from the second chamber; and an electrode configured to apply an electrical current to the first chamber of the working device to induce an ion current in the salt solution, wherein the ion current acts on the second chamber to iontophoretically transport therapeutic molecules across the surface overlaying the target region and/or debride biofilm at the surface overlaying the target region.